Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avis Budget

192.48
-3.6100-1.84%
Post-market: 192.480.00000.00%18:35 EDT
Volume:597.00K
Turnover:114.69M
Market Cap:6.77B
PE:-3.08
High:198.00
Open:198.00
Low:189.61
Close:196.09
Loading ...

Avis Budget Group, Hertz Global Holdings Could Benefit From US Tariffs, BofA Securities Says

MT Newswires Live
·
11 Apr

Ford, GM, Stellantis Face $41.9 Billion Higher Cost From Tariffs, CAR Report Says

MT Newswires Live
·
11 Apr

Bank of America Securities Keeps Their Buy Rating on Avis Budget (CAR)

TIPRANKS
·
11 Apr

Avalon GloboCare Secures Patent for CAR-T Technology

TIPRANKS
·
10 Apr

Avalon announces issuance of patent for CAR-T, CAR-NK cell technology in China

TIPRANKS
·
10 Apr

Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

GlobeNewswire
·
10 Apr

CAR Bull Sees Demand Supporting Brazil Business -- Market Talk

Dow Jones
·
10 Apr

CAR Benefits From Demand in North America Despite Rising Fleet Costs

Zacks
·
08 Apr

Ground Transportation Stocks Q4 Results: Benchmarking Landstar (NASDAQ:LSTR)

StockStory
·
08 Apr

Allogene Therapeutics granted three Fast Track Designations for ALLO-329

TIPRANKS
·
07 Apr

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

GlobeNewswire
·
07 Apr

Battle of the online classifieds: Should I buy Car Group or Seek shares?

MotleyFool
·
07 Apr

Celyad Oncology Reports 2024 Financial Results and Advances in CAR T-Cell Therapies

TIPRANKS
·
05 Apr

Car Rental Companies Could Benefit From Tariffs -- Market Talk

Dow Jones
·
04 Apr

Used-car sellers should benefit from tariffs - here's why the stocks are down

Dow Jones
·
03 Apr

INOVIQ Unveils CAR-Exosome Therapeutic Program in Investor Briefing

TIPRANKS
·
03 Apr

Chase the Rebound in Avis (CAR) Stock Amid Trump's Auto Tariff Boost?

Zacks
·
03 Apr

Press Release: Celyad Oncology Reports Full Year 2024 Financial Results and Recent Business Highlights

Dow Jones
·
03 Apr

CAR Group Bull Positive on Its U.S. RV Platform -- Market Talk

Dow Jones
·
01 Apr

Kyverna Therapeutics Advances CAR T-Cell Therapy Trials

TIPRANKS
·
29 Mar